| Literature DB >> 21887374 |
Julia Schumann1, Alexander Leichtle, Joachim Thiery, Herbert Fuhrmann.
Abstract
The eukaryotic cell membrane possesses numerous complex functions, which are essential for life. At this, the composition and the structure of the lipid bilayer are of particular importance. Polyunsaturated fatty acids may modulate the physical properties of biological membranes via alteration of membrane lipid composition affecting numerous physiological processes, e.g. in the immune system. In this systematic study we present fatty acid and peptide profiles of cell membrane and membrane rafts of murine macrophages that have been supplemented with saturated fatty acids as well as PUFAs from the n-3, the n-6 and the n-9 family. Using fatty acid composition analysis and mass spectrometry-based peptidome profiling we found that PUFAs from both the n-3 and the n-6 family have an impact on lipid and protein composition of plasma membrane and membrane rafts in a similar manner. In addition, we found a relation between the number of bis-allyl-methylene positions of the PUFA added and the unsaturation index of plasma membrane as well as membrane rafts of supplemented cells. With regard to the proposed significance of lipid microdomains for disease development and treatment our study will help to achieve a targeted dietary modulation of immune cell lipid bilayers.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21887374 PMCID: PMC3161109 DOI: 10.1371/journal.pone.0024066
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fatty acid patterns [nmol/mg protein] and MBI in plasma membrane of PUFA supplemented cells.
| Basic medium | LNA | EPA | DHA | LA | γ-LNA | AA | |
|
| 53.4±17.1a | 324.0±220.9a | 388.3±20.4c | 231.2±16.8b | 48.2±11.1a | 33.1±4.2a | 42.5±21.1a |
|
| 119.4±39.9a | 113.2±62.9a | 77.2±6.8a | 55.1±4.4b | 302.9±40.8c | 251.3±38.2c | 315.8±39.8c |
|
| 572.7±68.3a | 415.1±132.5a | 531.9±21.4a | 355.9±19.6b | 413.8±60.4b | 360.0±53.0b | 319.4±55.5b |
|
| 607.4±218.6a | 504.9±83.8a | 276.9±68.0b | 164.1±12.5c | 375.2±95.0a | 208.9±15.2b | 467.6±190.5a |
|
| 766.3±130.2a | 764.4±125.6a | 1136.0±63.4b | 514.3±54.8c | 698.7±90.2a | 719.5±280.7a | 722.4±362.7a |
|
| 21.3±5.2a | 63.5±36.2a | 74.0±5.0c | 93.5±4.9d | 44.0±4.1b | 49.6±11.2b | 64.6±14.9b |
Fatty acid patterns [nmol/mg protein] and Methylene Bridge Index (MBI) in plasma membrane of RAW264.7 cultured for 72h in basic medium as well as in medium supplemented with 15 µmol/l alpha-linolenic acid (LNA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA), gamma-linolenic acid (γ-LNA) and arachidonic acid (AA) respectively. Data are mean±S.D. (n = 6). Superscript letters across a row denote significant differences.
Fatty acid patterns [nmol/mg protein] and MBI in membrane rafts of PUFA supplemented cells.
| Basic medium | LNA | EPA | DHA | LA | γ-LNA | AA | |
|
| 4.3±10.5a | 279.0±318.1a | 200.6±39.5b | 154.2±9.2b | n.d. | n.d. | n.d. |
|
| 79.6±9.6a | 135.0±73.5a | 79.0±11.3a | 89.0±34.0a | 251.3±116.2b | 179.2±37.0b | 196.1±45.0b |
|
| 604.7±81.2a | 382.9±121.6b | 425.6±98.4b | 303.8±41.6b | 419.4±130.0a | 209.9±53.0c | 264.0±44.3b |
|
| 1224.0±505.7a | 1403.0±500.6a | 480.0±41.8b | 407.5±240.0b | 1089.0±133.8a | 553.3±276.3a | 1458.0±169.0a |
|
| 534.4±52.4a | 402.9±220.9a | 818.4±349.4a | 388.1±482.0a | 385.6±139.8a | 100.6±34.0c | 251.6±64.9b |
|
| 6.7±5.8a | 44.6±42.0a | 50.0±11.1bc | 78.4±35.4c | 20.6±8.2b | 46.8±28.1b | 23.4±5.5b |
Fatty acid patterns [nmol/mg protein] and Methylene Bridge Index (MBI) in membrane rafts of RAW264.7 cultured for 72h in basic medium as well as in medium supplemented with 15 µmol/l alpha-linolenic acid (LNA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA), gamma-linolenic acid (γ-LNA) and arachidonic acid (AA) respectively. Data are mean±S.D. (n = 6). Superscript letters across a row denote significant differences. n.d. = below detection limit.
Fatty acids [nmol/mg protein] dominating in plasma membrane and membrane rafts of cells cultured in basic medium.
| Plasma membrane | Membrane rafts | |
|
| 1115.0±498.6a | 506.5±205.0a |
|
| 377.4±74.4a | 331.1±48.0a |
|
| 217.3±11.4a | 203.0±18.2a |
|
| 128.9±39.5a | 178.7±32.9a |
|
| 156.3±41.0a | 434.6±127.5b |
|
| 126.4±11.5a | 97.5±11.9b |
Fatty acids [nmol/mg protein] dominating in plasma membrane and membrane rafts of RAW264.7 cultured for 72h in basic medium. Data are mean±S.D. (n = 6). Superscript letters across a row denote significant differences. C18∶1n9: oleic acid; C18∶1n7: vaccenic acid; C16∶1n7: palmitoleic acid; C18∶0: stearic acid; C16∶0: palmitic acid; C14∶0: myristic acid.
Peptide profiles of plasma membrane and membrane rafts.
| Plasma membrane( | Membrane rafts( | Notions |
| 1015 | 1015 | Sensitive to fatty acid composition of membrane rafts |
| 1043 | 1043 | Sensitive to fatty acid composition of membrane rafts |
| 1052 | 1052 | |
| 1059 | 1059 | Sensitive to fatty acid composition of membrane rafts |
| 1067 | 1067 | |
| 1073 | 1073 | |
| 1083 | 1083 | |
| 1087 | 1087 | Sensitive to fatty acid composition of membrane rafts |
| 1115 | 1115 | Sensitive to fatty acid composition of membrane rafts |
| 1131 | 1131 | |
| 1147 | 1147 | |
| 1165 | Unique peak for plasma membrane | |
| 1190 | 1190 | |
| 1200 | 1200 | |
| 1263 | 1263 | |
| 1275 | 1275 | |
| 1280 | 1280 | |
| 1291 | 1291 | |
| 1310 | 1310 | |
| 1334 | 1334 | |
| 1385 | 1385 | |
| 1390 | Unique peak for plasma membrane; Sensitive to fatty acid composition of plasma membrane | |
| 1408 | 1408 | |
| 1448 | 1448 | |
| 1461 | 1461 | Sensitive to fatty acid composition of plasma membrane and membrane rafts |
| 1511 | Unique peak for plasma membrane | |
| 1516 | 1516 | Sensitive to fatty acid composition of plasma membrane |
| 1534 | 1534 | |
| 1552 | 1552 | |
| 1575 | 1575 | Sensitive to fatty acid composition of plasma membrane |
| 1618 | 1618 | |
| 2211 | 2211 | |
| 2378 | Unique peak for plasma membrane | |
| 2868 | 2868 | |
| 2909 | 2909 | |
| 2995 | 2995 | |
| 3012 | 3012 | |
| 3035 | 3035 | |
| 3050 | 3050 | |
| 3066 | 3066 | Sensitive to fatty acid composition of plasma membrane |
| 3175 | 3175 | |
| 3192 | 3192 | |
| 3217 | 3217 | |
| 3779 | 3779 | |
| 3796 | 3796 | |
| 3820 | 3820 | |
| 3853 | 3853 | |
| 3906 | 3906 | |
| 3922 | 3922 | |
| 3947 | 3947 | |
| 3979 | 3979 | |
| 3996 | 3996 | |
| 4020 | 4020 | |
| 4286 | Unique peak for plasma membrane | |
| 4583 | 4583 | |
| 4709 | 4709 | |
| 4725 | 4725 | |
| 4751 | 4751 | |
| 4968 | 4968 | |
| 4983 | 4983 | |
| 5008 | Unique peak for plasma membrane | |
| 6116 | 6116 | |
| 6175 | 6175 | |
| 6214 | 6214 | |
| 6231 | 6231 | |
| 6256 | 6256 | |
| 6288 | 6288 | |
| 6304 | 6304 | |
| 6377 | 6377 | |
| 7112 | 7112 | |
| 7771 | Unique peak for plasma membrane; Sensitive to fatty acid composition of plasma membrane | |
| 9108 | Unique peak for plasma membrane |
Peptide profiles of plasma membrane and membrane rafts of RAW264.7 cultured for 72h in basic medium. Peptidome separation was done using the CLINPROT profiling purification kit from Bruker Daltonics (Billerica, USA) by means of magnetic particles with magnetic bead-hydrophobic interaction (MB-HIC C8).